Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B) - Trial UMIN000050878
Access comprehensive clinical trial information for UMIN000050878 through Pure Global AI's free database. This phase not specified trial is sponsored by North East Japan Study Group (NEJSG) and is currently Enrolling by invitation. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050878
Enrolling by invitation
Trial Details
University Hospital Medical Information Network • UMIN000050878
Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B)
Study Focus
Observational
Sponsor & Location
North East Japan Study Group (NEJSG)
Japan
Timeline & Enrollment
N/A
Mar 31, 2023
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000050878
Non-Device Trial